Matthew J Wasco

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. doi Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration
    Matthew J Wasco
    The University of Michigan Medical School, Department of Pathology, Ann Arbor, Michigan 48109 0602, USA
    Diagn Cytopathol 36:568-73. 2008
  2. doi IMP-3 expression in melanocytic lesions
    Limin Yu
    Department of Pathology, Dermatopathology Division, University of Michigan, M3260, Medical Sciences 1, 1301 Catherine Street, Ann Arbor, MI 48109 0602, USA
    J Cutan Pathol 37:316-22. 2010
  3. doi Utility of antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma
    Matthew J Wasco
    Department of Pathology, The University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Appl Immunohistochem Mol Morphol 16:349-56. 2008
  4. doi Multiple adverse histological features increase the odds of under staging T1 bladder cancer
    Alon Z Weizer
    Department of Urology, University of Michigan, Ann Arbor, Michigan, USA
    J Urol 182:59-65; discussion 65. 2009
  5. doi Expression of gamma-H2AX in melanocytic lesions
    Matthew J Wasco
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
    Hum Pathol 39:1614-20. 2008
  6. doi Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics
    Jason C Carvalho
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI, USA
    Histopathology 58:169-79. 2011
  7. doi Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases
    Matthew J Wasco
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
    Hum Pathol 41:163-71. 2010
  8. ncbi Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection
    Matthew J Wasco
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Urology 70:69-74. 2007

Detail Information

Publications8

  1. doi Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration
    Matthew J Wasco
    The University of Michigan Medical School, Department of Pathology, Ann Arbor, Michigan 48109 0602, USA
    Diagn Cytopathol 36:568-73. 2008
    ..A combination of all 3 markers identified 87% of cases, and failure to stain for both PAX-2 and gamma-H2AX suggests against, but does not disprove, a diagnosis of RCC...
  2. doi IMP-3 expression in melanocytic lesions
    Limin Yu
    Department of Pathology, Dermatopathology Division, University of Michigan, M3260, Medical Sciences 1, 1301 Catherine Street, Ann Arbor, MI 48109 0602, USA
    J Cutan Pathol 37:316-22. 2010
    ..However, the expression of IMP-3 has not been explored in melanoma in situ, various histologic subtypes of invasive melanomas and atypical Spitz tumors...
  3. doi Utility of antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma
    Matthew J Wasco
    Department of Pathology, The University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Appl Immunohistochem Mol Morphol 16:349-56. 2008
    ..RCC-Ma is 100% specific for RCC, but only when a membranous pattern of staining is interpreted as positive...
  4. doi Multiple adverse histological features increase the odds of under staging T1 bladder cancer
    Alon Z Weizer
    Department of Urology, University of Michigan, Ann Arbor, Michigan, USA
    J Urol 182:59-65; discussion 65. 2009
    ..In this study we evaluated clinicopathological features to aid in the identification of patients with clinical T1 bladder cancer at risk for under staging...
  5. doi Expression of gamma-H2AX in melanocytic lesions
    Matthew J Wasco
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
    Hum Pathol 39:1614-20. 2008
    ..Based on the overlap in subsets of nevi and melanomas, the potential clinical utility of this antibody remains uncertain until further studies have been carried out in a larger cohort of melanocytic lesions, including borderline cases...
  6. doi Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics
    Jason C Carvalho
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI, USA
    Histopathology 58:169-79. 2011
    ....
  7. doi Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases
    Matthew J Wasco
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
    Hum Pathol 41:163-71. 2010
    ..78). Increased awareness and familiarity with the clinicopathologic spectrum is critical for confident recognition and adequate management of this very aggressive variant of UC...
  8. ncbi Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection
    Matthew J Wasco
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Urology 70:69-74. 2007
    ..This study examined the incidence, pathologic spectrum, and clinical significance of this phenomenon...